CA 15-3 predicts outcome in breast cancer patients

被引：0
|
作者：
Shering, SG
Duffy, MJ
McDermot, EW
OHiggins, NJ
机构：
[1] ST VINCENTS HOSP,UNIV COLL DUBLIN,DEPT SURG,DUBLIN 4,IRELAND
[2] ST VINCENTS HOSP,UNIV COLL DUBLIN,DEPT NUCL MED,DUBLIN 4,IRELAND
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：680 / 680
页数：1
相关论文
共 50 条
  • [41] Serum CEA and CA 15-3 levels according to breast cancer subtypes
    Dede, Isa
    Utkan, Gungor
    Akbulut, Hakan
    Urun, Yuksel
    Mizrak, Dilsa
    Icli, Fikri
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Clinical significance of CA 15-3 and CEA in detection of breast cancer recurrence
    Mok, C. W.
    Lim, S. K.
    Seah, J.
    Kam, J. W.
    Tan, S. M.
    BREAST, 2015, 24 : S107 - S108
  • [43] CEA and CA 15-3 in invasive breast carcinoma
    Prtenjak, G
    Pap, D
    CLINICA CHIMICA ACTA, 2005, 355 : S435 - S436
  • [44] CA 15-3 and bone scintigraphy in the follow-up of breast cancer
    Younsi, N
    Montravers, F
    Philippe, C
    Seddiki, M
    Uzan, S
    Izrael, V
    Talbot, JN
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1997, 12 (04): : 154 - 157
  • [45] Are CA 15-3, CEA and CA 125 Predictors for Lymphatic and Vascular Spread In Breast Cancer?
    Atalay, Can
    ERCIYES MEDICAL JOURNAL, 2008, 30 (04) : 218 - 224
  • [46] Early treatment of metastatic breast cancer patients after increase of CEA or CA 15-3 serumlevels
    Kramer, S
    Jager, W
    Katalinic, A
    Lang, N
    10TH INTERNATIONAL MEETING OF GYNAECOLOGICAL ONCOLOGY, 1997, : 393 - 396
  • [47] Comparing the performance of CA 15-3 CSF to cytology in a cohort of patients with breast cancer leptomeningeal metastasis
    Kenyon, Stacy M.
    Flieth, Tifani L.
    Algeciras-Schimnich, Alicia
    CLINICAL BIOCHEMISTRY, 2018, 58 : 122 - 124
  • [48] COMPARISON OF BREAST-CANCER MUCIN (BCM) AND CA 15-3 IN HUMAN BREAST-CANCER
    GARCIA, MB
    BLANKENSTEIN, MA
    VANDERWALL, E
    NORTIER, JWR
    SCHORNAGEL, JH
    THIJSSEN, JHH
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 17 (02) : 69 - 76
  • [49] SERUM CEA, CA 15-3, AND MCA IN BREAST-CANCER PATIENTS - A CLINICAL-EVALUATION
    REPETTO, L
    ONETTO, M
    GARDIN, G
    COSTANZI, B
    GIUDICI, S
    VITIELLO, E
    MERLINI, L
    NASO, C
    ZANNINI, C
    PAGANUZZI, M
    ROSSO, R
    SANTI, L
    CANCER DETECTION AND PREVENTION, 1993, 17 (03): : 411 - 415
  • [50] Serum markers TPS, TPA and CA 15-3 as monitors of chemotherapy in patients with metastatic breast cancer
    Lindman, H
    Jansson, T
    Arnberg, H
    Bergh, J
    Einarsson, R
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2000, 15 (03): : 177 - 186
12345